According to U.S. health officials, doctors should use the anemia drugs Procrit, Epogen and Aranesp more cautiously in patients with chronic kidney disease.
The new warning comes in response to data showing that patients on these drugs face a higher risk of cardiovascular problems such as heart attack, heart failure, stroke, blood clots and death. Read
See also: 7 Simple Steps for Heart Health
Discounts & Benefits
Next ArticleRead This